期刊文献+

3C疗法治疗1型糖尿病儿童维生素D水平研究 被引量:2

Effects of 3C Therapy on Vitamin D Levels of Children with Type 1 Diabetes Mellitus
下载PDF
导出
摘要 目的:评估维生素D与1型糖尿病(T1DM)患儿的临床关系,为T1DM的防治提供新的依据。方法:选取我院2017-2018年新诊断及使用3C疗法治疗的T1DM患儿,分析T1DM患儿与健康体检患儿血清25-羟维生素D[25(OH)D]水平。根据25(OH)D水平,将T1DM患儿分为三组(缺乏组、不足组及充足组),比较三个亚组的性别、年龄、居住地、体质量指数(BMI)、空腹C肽、空腹血糖及胰岛素用量等情况,探讨不同tanner分期、性别、季节、有无合并糖尿病酮症酸中毒(DKA)与血清维生素D水平的关系。结果:T1DM组患儿血清25(OH)D水平为(42.31±22.01)nmol/L,较健康对照组的(50.37±22.28)nmol/L低,差异有统计学意义(P<0.05)。T1DM组患儿中,维生素D充足组的空腹C肽水平高于维生素D不足组及维生素D缺乏组(P<0.05);维生素D缺乏组空腹血糖水平及单位体质量胰岛素用量高于维生素D充足组(P<0.05)。按血清25(OH)D水平测定时间不同分A组(1-3月、10-12月)和B组(4-9月),A组25(OH)D水平低于B组(P<0.05);合并DKA组25(OH)D水平低于无DKA组(P<0.05)。结论:T1DM患儿普遍存在维生素D缺乏,尤其是合并DKA、1-3月及10-12月的患儿;维生素D充足的T1DM患儿可减少胰岛素用量。临床上要加强T1DM患儿的维生素D的监测以及补充。 Objective:To evaluate the clinical correlation between vitamin D and children with type 1 diabetes mellitus(T1DM)and provide new basis for the prevention and treatment of T1DM.Methods:Children newly diagnosed with T1DM and treated with 3C therapy in our hospital from 2017 to 2018 were selected,the serum level of 25-hydroxyvitamin D(25(OH)D)of children with T1DM and children with healthy physical examination were analyzed.According to the levels of 25(OH)D,children with T1DM were divided into 3 subgroups(deficient group,insufficient group and sufficient group).The gender,age,residence,body mass index(BMI),fasting C-peptide,fasting blood glucose and insulin dosage of three subgroups were compared.The correlation between different tanner stages,gender,season,presence or absence of diabetic ketoacidosis(DKA)and serum vitamin D levels was investigated.Results:The serum level of 25(OH)D in the T1DM group was(42.31±22.01)nmol/L,lower than that in the healthy control group(50.37±22.28)nmol/L,and the difference was statistically significant(P<0.05).In the T1DM group,the fasting C-peptide level of the vitamin D sufficient group was higher than that of the vitamin D insufficient group and the vitamin D deficient group(P<0.05).The fasting blood glucose level and the amount of insulin per body mass in the vitamin D deficit group were higher than those in the vitamin D sufficient group(P<0.05).According to the measurement time of 25(OH)D,all patients can be divided into the group A(from Jan.to Mar.,from Oct.to Dec.)and group B(from Apr.to Sept.months),the level of 25(OH)D in group A was lower than that in group B(P<0.05).The level of 25(OH)D in patients with DKA was lower than that in patients without DKA(P<0.05).Conclusion:Vitamin D deficiency is common in children with T1DM,especially in children with DKA from Jan.to Mar.and from Oct.to Dec.Children with T1DM with sufficient vitamin D can reduce the insulin dosage.It is necessary to strengthen the monitoring and supplement of vitamin D in children with T1DM.
作者 鄢力 程昕然 龚春竹 唐芳 苟鹏 李中会 苏娜 冷洁 汪柳旭 杜思泓 张红 许珂 Yan Li;Cheng Xinran;Gong Chunzhu;Tang Fang;Gou Peng;Li Zhonghui;Su Na;Leng Jie;Wang Liuxu;Du Sihong;Zhang Hong;Xu Ke(Affiliated Hospital of School of Medicine,University of Electronic Science and Technology of China,Chengdu Women*s&Children's Central Hospital,Sichuan Chengdu 611731,China)
出处 《儿科药学杂志》 CAS 2020年第12期10-14,共5页 Journal of Pediatric Pharmacy
基金 四川省卫生和计划生育委员会科研课题重点研究项目,编号17PJ273 四川省科技计划资助项目,编号2019JDPT0034。
关键词 维生素D 1型糖尿病 儿童 3C疗法 vitamin D type 1 diabetes mellitus children 3C therapy
  • 相关文献

参考文献5

二级参考文献21

  • 1I Cutolo M. Vitamin D and autoimmune rheumatic diseases [ J 1. Rheumatology ( Oxford), 2009, 48 (3) : 210-212.
  • 2Steinman RM, Banchereau J. Taking dendritic cells into medicine [J]. Nature, 2007, 449(7161 ): 419-426.
  • 3Kamen D, Aranow C. Vitamin D in systemic lupus erythematosus [J]. Current opinion in rheumatology, 2008, 20(5) : 532-537.
  • 4Pelajo CF, Lopez-Benitez JM, Miller LC. Vitanfin D andautoimmune rheumatologic disorders [ Jl. Autoimmunity reviews, 2010, 9(7) : 507-510.
  • 5Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases [ J ]. hnmunity, 2006, 25(3) : 383-392.
  • 6Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology [J]. FASEB J, 2001, 15(14): 2579-2585.
  • 7Linker-Israeli M, Elstner E, Klinenberg JR, et al. Vitamin Dz and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC [ J 1. Clin Immunol, 2001, 99( 1 ) : 82-93.
  • 8Orbach H, Zandman-Goddard G, Amital H, et al. Novel biomarkers in autoimmune diseases : prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases [ J 1- Annals of the New York Academy of Sciences, 2007, 1109 : 385-400.
  • 9Chen S, Sims GP, Chen XX, et al. Modulatory effects of 1,25- dihydroxyvitamin D3 on human B cell differentiation [ J ]. J Immunol, 2007, 179 (3) : 1634-1647.
  • 10Drexler SK, Kong PL, Wales J, et al. Cell signalling in rnacrophages, the principal innate immune effector cells of rheumatoid arthritis [ J]. Arthritis research & therapy, 2008, 10 (5) : 216.

共引文献26

同被引文献15

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部